Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Williams, MD
Cambridge University Hospitals NHS Foundation Trust
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Addenbrooke'S Hospital
Cambridge, England, United Kingdom
- Leeds Cancer Centre at St. James'S University Hospital
Leeds, England, United Kingdom
- Saint Bartholomew'S Hospital
London, England, United Kingdom
- Northern Centre for Cancer Treatment at Newcastle General Hospital
Newcastle upon Tyne, England, United Kingdom
- Churchill Hospital
Oxford, England, United Kingdom
- Edinburgh Cancer Centre at Western General Hospital
Edinburgh, Scotland, United Kingdom
- Beatson West of Scotland Cancer Centre
Glasgow, Scotland, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2004
- Primary completion
- 31 Dec 2008
- Completion
- 31 Jan 2009
- Last update posted
- 7 Aug 2013
- Registered enrollment
- 20
- Registry id
- NCT00453232
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.